RBBP6 and cancer: Combinational therapy identifies the molecular effect in cancer cells and replaces it, followed by chemotherapy or any appropriate therapy resulting in much improved and side-effect-free treatment.12 We then went on to exploit the combinational mixture of RBBP6-silencing and apoptosis-inducing anticancer agents, camptothecin and GABA, to verify if our hypothesis might be true for MDA-MB-231 since they failed to elicit significant levels of apoptosis induction when treated with siRBBP6 only.